Skip to main content
logo
Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
31.99
-0.44 (-1.36%)
At close: Aug 10, 2026, 4:00 PM EDT
31.99
0.00 (0.00%)
After-hours: Aug 10, 2026, 4:10 PM EDT

Zenas BioPharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
010550-
Revenue Growth
-100.00%-90.00%--
Gross Profit
010550-
Operating Income
-423.08-383.06-163.89-37.15-76.2
Net Income
-425.15-377.74-156.99-37.12-119.28
Earnings Per Share
-8.47-8.44-11.89-24.25-79.94
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
717.21343.19350.7756.8667.21
Total Debt
266.831.3310.811.53
Net Cash (Debt)
450.38341.87349.7656.0465.68
Net Cash Growth
44.74%-2.26%524.09%-14.67%-
Net Cash Per Share
9.357.647.820.040.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-210.48-172.33-119.67-30.53-65.65
Capital Expenditures
-0-0.02-0.13-0.02-0.2
Free Cash Flow
-210.48-172.35-119.81-30.55-65.85
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
-100.00%100.00%100.00%-
Operating Margin
--3830.57%-3277.76%-74.29%-
Pretax Margin
--3778.16%-3131.18%-73.65%-
Profit Margin
--3777.37%-3139.76%-73.04%-
FCF Margin
--1723.51%-2396.10%-61.09%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
-197.8468.46--